Mitral regurgitation

Disease2 papers

Humans2

Trial sponsors

Edwards Lifesciences
Company1 trial786 people

Latest

7

European Journal of Preventive CardiologyHumans16 Sep

Metabolic obesity phenotypes and degenerative valvular heart disease: A cohort study

Journal of Clinical MedicineReview27 Aug

Sodium-Glucose Cotransporter 2 Inhibitors in Valvular Heart Disease: Cardiovascular Benefit, Valve-Specific Effects, and Evidence Gaps-A Structured Narrative Review

SGLT2 inhibitors

International Journal of Cardiology Heart & VasculatureHumans23 Aug

Influence of age, frailty and non-cardiac comorbidities on survival in patients undergoing mitral valve edge-to-edge repair - a perspective from the German health care system

AHA Scientific Sessions 2025 AbstractHumans3 Nov

Impact of Frailty on outcomes after transcatheter-edge-to-edge repair (TEER) in patients with mitral regurgitation (MR)

AHA Scientific Sessions 2025 AbstractHumans3 Nov

Structural Cardiac Abnormalities Modify Atrial Fibrillation–Associated Heart Failure Risk and Identify a High-Risk Phenotype in Older Adults: The ARIC Study

AHA Scientific Sessions 2025 AbstractHumans3 Nov

Impact of Mitral Valve Intervention and Frailty on Outcomes of Severe Mitral Regurgitation due to Severe Mitral Annular Calcification

AHA Scientific Sessions 2025 AbstractHumans3 Nov

Elevated Body Mass Index Predicts New-Onset Heart Failure Following Catheter Ablation for Atrial Fibrillation